The current price is in 2,61$, Trevi Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Danine Summers (Vice President-Medical Affairs), Jennifer L. Good (President, Chief Executive Officer & Director), Lisa Delfini (Chief Financial Officer), Thomas R. Sciascia (Chief Medical Officer) and its address is 195 CHURCH STREET 14TH FLOOR, NEW HAVEN, Connecticut, 6510, United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 2,57$ moving between 2,48$ and 2,65$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
